You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Immunoregulation

Showing 1 - 25 of 66
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Monkeypox Trial in United States (JYNNEOS)

Not yet recruiting
  • Monkeypox
  • JYNNEOS
  • San Diego, California
  • +7 more
Aug 20, 2022

Monkeypox Trial in Puerto Rico, United States (JYNNEOS)

Not yet recruiting
  • Monkeypox
  • JYNNEOS
  • Birmingham, Alabama
  • +13 more
Feb 13, 2023

Kidney Transplantation, Rituximab (RTx), Living Donors Trial in Giessen (Rituximab, living donor transplantation, deceased donor

Completed
  • Kidney Transplantation
  • +4 more
  • Giessen, Germany
    Department of Internal Medicine, University of Giessen
Oct 7, 2019

Study of Autoimmune Lymphoproliferative Syndrome (ALPS)

Recruiting
  • Benign Lymphoproliferative Disorder
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Feb 2, 2023

    Multiple Sclerosis Trial in Berlin (Hypoxic training, Normoxic training)

    Completed
    • Multiple Sclerosis
    • Hypoxic training
    • Normoxic training
    • Berlin, Germany
      Experimental & Clinical Research Center
    Jul 7, 2022

    Healthy Trial in Berlin (Slow sodium tablets)

    Completed
    • Healthy
    • Slow sodium tablets
    • Berlin, Germany
      Experimental & Clinical Research Center
    Jul 7, 2022

    Host Response to Infection and Treatment in Filarial Diseases

    Recruiting
    • Filariasis
    • +4 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 31, 2023

    Circulating Cluster of Differentiation 4 Positive 28 Null T

    Not yet recruiting
    • Autoimmune Hemolytic Anemia
      • (no location specified)
      Jan 31, 2023

      COVID-19 Trial in Worldwide (Placebo, Remdesivir)

      Completed
      Has Results
      • COVID-19
      • Birmingham, Alabama
      • +59 more
      Mar 9, 2022

      COVID-19 Trial in Worldwide (Interferon beta-1a, Placebo, Remdesivir)

      Completed
      Has Results
      • COVID-19
      • Interferon beta-1a
      • +2 more
      • Birmingham, Alabama
      • +63 more
      Mar 9, 2022

      COVID-19 Trial in Worldwide (Baricitinib, Dexamethasone, Placebo)

      Completed
      Has Results
      • COVID-19
      • Birmingham, Alabama
      • +71 more
      Jun 22, 2022

      HIV Infected Previously Participated in HIV Clinical Trials

      Completed
      • HIV Infections
        • (no location specified)
        Oct 28, 2021

        Pneumonia Post Haematopoietic Stem Cell Transplantation

        Completed
        • Pneumonia
        • Hematopoietic Stem Cell Transplantation
          • Guangzhou, Guangdong, China
            Guangzhou Women and Children's Medical Center
          Nov 22, 2021

          COVID-19 Trial in Worldwide (Placebo, Remdesivir, Baricitinib)

          Completed
          Has Results
          • COVID-19
          • Placebo
          • +2 more
          • Birmingham, Alabama
          • +70 more
          Mar 9, 2022

          Analysis of Intestinal Defensin Expression in Acute GVHD

          Active, not recruiting
          • GVHD,Acute
          • +2 more
            • Freiburg, Baden-Württemberg, Germany
              Medical Center University of Freiburg
            Nov 3, 2021

            Neurologic Disorders, Nervous System Diseases, Neurodegenerative Diseases Trial in Westport, Coral Springs, Dubai (Intravenous

            Recruiting
            • Neurologic Disorders
            • +25 more
            • Intravenous and Intranasal BMSC
            • Westport, Connecticut
            • +2 more
            Nov 25, 2022

            HIV Trial run by the NIAID (Interleukin-2)

            Completed
            • HIV Infections
            • Bethesda, Maryland
              NIH Intramural Research Program ACTG CRS
            Oct 28, 2021

            NSCLC Trial in Guangzhou (PEF, Anti-PD-1 mAb)

            Recruiting
            • NSCLC
            • PEF
            • Anti-PD-1 monoclonal antibody
            • Guangzhou, Guangdong, China
              The first Affiliated Hospital of Guangzhou Medical University
            Aug 3, 2023

            Covid19, Inflammation Trial in Salvador (Standardized Brazilian Green Propolis Extract, Placebo)

            Completed
            • Covid19
            • Inflammation
            • Standardized Brazilian Green Propolis Extract
            • Placebo
            • Salvador, BA, Brazil
              Hospital Sao Rafael
            May 11, 2022

            Hip Osteoarthritis Trial (Leukocyte Rich- PRP injection, Leukocyte Poor- PRP injection)

            Not yet recruiting
            • Hip Osteoarthritis
            • Leukocyte Rich- PRP injection
            • Leukocyte Poor- PRP injection
            • (no location specified)
            Aug 9, 2022

            Radiation-Induced Mucositis Trial in Cairo (Glutamine)

            Recruiting
            • Radiation-Induced Mucositis
            • Glutamine
            • Cairo, Egypt
            • +1 more
            May 3, 2023

            Atezolizumab Plus Bevacizumab in Advanced HCC

            Recruiting
            • Advanced Hepatocellular Carcinoma
            • Atezolizumab plus bevacizumab
            • Seongnam-si, Gyeonggi-do, Korea, Republic of
              Cha Medical Center
            Oct 30, 2022

            Rheumatoid Arthritis, Ankylosing Spondylitis, Systemic Lupus Erythematosus Trial in Paris, Villejuif, Créteil (Interleukin 2)

            Completed
            • Rheumatoid Arthritis
            • +13 more
            • Interleukin 2
            • Paris, Ile De France, France
            • +10 more
            Jul 19, 2021

            SARS-CoV-2 Infection Trial in Vitoria (ChAdOx1 nCoV-19 vaccine (AZD1222))

            Recruiting
            • SARS-CoV-2 Infection
            • ChAdOx1 nCoV-19 vaccine (AZD1222)
            • Vitoria, Espirito Santo, Brazil
              Federal University of Espirito Santo
            Nov 23, 2021

            Type 1 Diabetes Trial in Worldwide (rhIL-2, Placebo)

            Active, not recruiting
            • Type 1 Diabetes
            • Liège, Province De Liège, Belgium
            • +33 more
            Feb 9, 2022